Metrovacesa S.A. (BME:MVC)
Spain · Delayed Price · Currency is EUR 10.64
+0.04 (0.38%)
Aug 21, 2026, 5:35 PM CET
Metrovacesa Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | 893.22 | 708.37 | 653.07 | 580.62 | 515.75 | 512.1 |
| 893.22 | 708.37 | 653.07 | 580.62 | 515.75 | 512.1 | |
Revenue Growth (YoY | 60.87% | 8.47% | 12.48% | 12.58% | 0.71% | 266.21% |
Property Expenses | 673.06 | 528.83 | 529.72 | 458.84 | 422.13 | 407.32 |
Selling, General & Administrative | 35.24 | 32.16 | 34.81 | 33.46 | 34.23 | 36.57 |
Other Operating Expenses | 19.41 | 19.84 | 15.79 | 19.95 | 17.02 | 16.04 |
Total Operating Expenses | 727.71 | 582.05 | 576.99 | 515.43 | 479.98 | 454.56 |
Operating Income | 165.51 | 126.32 | 76.08 | 65.2 | 35.77 | 57.54 |
Interest Expense | -27.21 | -26.91 | -37.29 | -22.98 | -11.22 | -15.4 |
Interest & Investment Income | 10.52 | 11.65 | 14.68 | 2.24 | - | - |
Other Non-Operating Income | -0.32 | -1.57 | -3.09 | -3.99 | 4.86 | 0.34 |
EBT Excluding Unusual Items | 148.51 | 109.48 | 50.37 | 40.47 | 29.41 | 42.47 |
Gain (Loss) on Sale of Investments | -45.49 | -45.49 | -28.56 | -61.94 | -47.13 | -23.44 |
Asset Writedown | 10.92 | 8.55 | 2.65 | 4.96 | -0.55 | 4.69 |
Pretax Income | 113.94 | 72.54 | 24.46 | -16.51 | -18.28 | 23.73 |
Income Tax Expense | 23.75 | 15.68 | 8.58 | 4.34 | 5.2 | 5.27 |
Earnings From Continuing Operations | 90.19 | 56.86 | 15.89 | -20.84 | -23.48 | 18.46 |
Net Income | 90.19 | 56.86 | 15.89 | -20.84 | -23.48 | 18.46 |
Net Income to Common | 90.19 | 56.86 | 15.89 | -20.84 | -23.48 | 18.46 |
Net Income Growth | - | 257.94% | - | - | - | - |
Basic Shares Outstanding | 152 | 152 | 152 | 151 | 151 | 151 |
Diluted Shares Outstanding | 152 | 152 | 152 | 151 | 151 | 151 |
Shares Change | 0.02% | 0.03% | 0.03% | 0.04% | -0.01% | 0.00% |
EPS (Basic) | 0.59 | 0.38 | 0.10 | -0.14 | -0.16 | 0.12 |
EPS (Diluted) | 0.59 | 0.38 | 0.10 | -0.14 | -0.16 | 0.12 |
EPS Growth | - | 257.92% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Margin | 18.53% | 17.83% | 11.65% | 11.23% | 6.94% | 11.24% |
Profit Margin | 10.10% | 8.03% | 2.43% | -3.59% | -4.55% | 3.60% |
EBITDA | 166.19 | 127.54 | 79.26 | 68.38 | 42.37 | 63.62 |
EBITDA Margin | 18.61% | 18.00% | 12.14% | 11.78% | 8.21% | 12.42% |
D&A For Ebitda | 0.68 | 1.23 | 3.18 | 3.18 | 6.6 | 6.08 |
EBIT | 165.51 | 126.32 | 76.08 | 65.2 | 35.77 | 57.54 |
EBIT Margin | 18.53% | 17.83% | 11.65% | 11.23% | 6.94% | 11.24% |
Effective Tax Rate | 20.85% | 21.61% | 35.07% | - | - | 22.19% |